Equity Profile

IDXX

IDEXX Laboratories, Inc.

Health CareHealth Care Equipment$44.7B

Aug3Mon

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

IDEXX Laboratories, Inc. is a leading provider of diagnostic and information technology solutions for animal health, water testing, and dairy industries....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

$3.93

Revenue

Revenue figures provide insight into the company's sales performance and overall growth trajectory.

$1.2B

Wall Street expectations, options signals, track record, and call prep available with Pro.

IDXX Q2-2026 Earnings Preview

Context

Company Snapshot

IDEXX Laboratories, Inc. is a leading provider of diagnostic and information technology solutions for animal health, water testing, and dairy industries. Operating in the Health Care sector, IDEXX plays a crucial role in enhancing animal care and ensuring safe water supplies, which are increasingly important themes in public health and sustainability.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.46%

Avg Stock Reaction

+6.39%

Last Quarter Recap

In Q1-2026, IDEXX reported an EPS of $3.47, exceeding expectations by 1.49%. The stock experienced a slight decline of 0.03% the following day, reflecting cautious market sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect IDEXX to report solid earnings this quarter, with a consensus EPS of $3.93. The market is particularly focused on whether the company can maintain its growth momentum amidst competitive pressures.

Bull Case

If IDEXX exceeds EPS expectations and demonstrates strong revenue growth, it could signal robust demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it may raise concerns about its growth prospects, resulting in a negative stock response.

Key Metrics to Watch

EPS

$3.93

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

$1.2B

Revenue figures provide insight into the company's sales performance and overall growth trajectory.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed $3.93, and what factors contributed to this performance?

A beat on EPS would reinforce investor confidence in IDEXX's growth strategy and operational efficiency.

What is the outlook for revenue growth in the upcoming quarters?

Understanding revenue trends will help gauge the company's ability to sustain its growth in a competitive market.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate IDEXX's ability to innovate and capture market share, especially in emerging markets.

Supporting Evidence

IDEXX has a strong history of beating EPS estimates, with a 75% success rate over the last eight quarters.

The options market is pricing in a larger move than historical averages, suggesting that traders expect significant news or developments.

Recent trends in animal health and diagnostics indicate growing demand, which may not be fully reflected in current estimates.

Key Risk

If IDEXX's revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will indicate whether IDEXX can maintain its growth trajectory amidst market challenges.

Bull Confirmed If

An EPS of $4.00 or higher would confirm strong operational performance and demand for IDEXX's products.

Bear Confirmed If

An EPS below $3.81 could signal potential issues in sales or market share, leading to negative sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±17.90%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±17.9% while IDXX has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

31.3%

Calls (3K)P/C Ratio: 2.14Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IDEXX beats expectations, history suggests the stock could rise by around 8.77%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of approximately 0.73%, reflecting concerns about the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in diagnostic solutions.
2Insights into market demand trends, particularly in animal health and water testing.
3Management's commentary on competitive pressures and market share.
4Guidance on revenue growth expectations for the next quarter.
5Any strategic initiatives aimed at expanding into new markets or segments.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul31

SONYBMO

Sony Group Corporation

PreviewView

Jul31

ENBBMO

Company Snapshot

IDEXX Laboratories, Inc. is a leading provider of diagnostic and information technology solutions for animal health, water testing, and dairy industries....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

$3.93

Revenue

Revenue figures provide insight into the company's sales performance and overall growth trajectory.

$1.2B

Wall Street expectations, options signals, track record, and call prep available with Pro.

IDXX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.46%

Avg Stock Reaction

+6.39%

Last Quarter Recap

In Q1-2026, IDEXX reported an EPS of $3.47, exceeding expectations by 1.49%. The stock experienced a slight decline of 0.03% the following day, reflecting cautious market sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If IDEXX exceeds EPS expectations and demonstrates strong revenue growth, it could signal robust demand for its products, leading to a positive market reaction.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it may raise concerns about its growth prospects, resulting in a negative stock response.

Key Metrics to Watch

EPS

$3.93

Earnings per share is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue

$1.2B

Revenue figures provide insight into the company's sales performance and overall growth trajectory.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed $3.93, and what factors contributed to this performance?

A beat on EPS would reinforce investor confidence in IDEXX's growth strategy and operational efficiency.

What is the outlook for revenue growth in the upcoming quarters?

Understanding revenue trends will help gauge the company's ability to sustain its growth in a competitive market.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate IDEXX's ability to innovate and capture market share, especially in emerging markets.

Supporting Evidence

IDEXX has a strong history of beating EPS estimates, with a 75% success rate over the last eight quarters.

The options market is pricing in a larger move than historical averages, suggesting that traders expect significant news or developments.

Recent trends in animal health and diagnostics indicate growing demand, which may not be fully reflected in current estimates.

Key Risk

If IDEXX's revenue growth exceeds expectations, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will indicate whether IDEXX can maintain its growth trajectory amidst market challenges.

Bull Confirmed If

An EPS of $4.00 or higher would confirm strong operational performance and demand for IDEXX's products.

Bear Confirmed If

An EPS below $3.81 could signal potential issues in sales or market share, leading to negative sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±17.90%

Historical Avg

±10.0%

Pricing rich

The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±17.9% while IDXX has averaged ±10.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

31.3%

Calls (3K)P/C Ratio: 2.14Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IDEXX beats expectations, history suggests the stock could rise by around 8.77%, confirming strong demand and operational efficiency.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of approximately 0.73%, reflecting concerns about the company's growth prospects.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in diagnostic solutions.
2Insights into market demand trends, particularly in animal health and water testing.
3Management's commentary on competitive pressures and market share.
4Guidance on revenue growth expectations for the next quarter.
5Any strategic initiatives aimed at expanding into new markets or segments.